Literature DB >> 15273149

High prevalence of the ermB gene among erythromycin-resistant streptococcus pneumoniae isolates in Germany during the winter of 2000-2001 and in vitro activity of telithromycin.

Michael Kresken1, Beate Henrichfreise, Simone Bagel, Johannes Brauers, Bernd Wiedemann.   

Abstract

Of 595 isolates of Streptococcus pneumoniae from outpatients with respiratory tract infections, collected from 17 microbiology laboratories, 14.1% were resistant to erythromycin. Eighty-three erythromycin-resistant isolates were genetically analyzed, 83.1% of which harbored the ermB gene. Only four isolates (4.8%) harbored the mefA gene. Telithromycin exhibited potent activity against all isolates.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15273149      PMCID： PMC478534          DOI： 10.1128/AAC.48.8.3193-3195.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

Review 1.  Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.

Authors:  M C Roberts; J Sutcliffe; P Courvalin; L B Jensen; J Rood; H Seppala
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

2.  Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: results of a national surveillance study.

Authors:  R R Reinert; S Simic; A Al-Lahham; S Reinert; M Lemperle; R Lütticken
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

3.  Carriage of internationally spread clones of Streptococcus pneumoniae with unusual drug resistance patterns in children attending day care centers in Lisbon, Portugal.

Authors:  R Sá-Leão; A Tomasz; I S Sanches; A Brito-Avô; S E Vilhelmsson; K G Kristinsson; H de Lencastre
Journal:  J Infect Dis       Date:  2000-09-01       Impact factor: 5.226

4.  Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany.

Authors:  Ralf René Reinert; Adnan Al-Lahham; Maria Lemperle; Christoph Tenholte; Claudia Briefs; Stefan Haupts; Hans Hubert Gerards; Rudolf Lütticken
Journal:  J Antimicrob Chemother       Date:  2002-01       Impact factor: 5.790

5.  Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides.

Authors:  D J Hoban; A K Wierzbowski; K Nichol; G G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

Review 6.  Microbiological profile of telithromycin, the first ketolide antimicrobial.

Authors:  D Felmingham
Journal:  Clin Microbiol Infect       Date:  2001       Impact factor: 8.067

7.  Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci.

Authors:  Virginia D Shortridge; Ping Zhong; Zhensheng Cao; Jill M Beyer; Laurel S Almer; Nancy C Ramer; Stella Z Doktor; Robert K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

8.  Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece.

Authors:  G A Syrogiannopoulos; I N Grivea; A Tait-Kamradt; G D Katopodis; N G Beratis; J Sutcliffe; P C Appelbaum; T A Davies
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

9.  mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae.

Authors:  A Tait-Kamradt; J Clancy; M Cronan; F Dib-Hajj; L Wondrack; W Yuan; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

10.  Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae.

Authors:  John R Lonks; Javier Garau; Lucía Gomez; Mariona Xercavins; Anna Ochoa de Echagüen; Ilana F Gareen; Philip T Reiss; Antone A Medeiros
Journal:  Clin Infect Dis       Date:  2002-08-09       Impact factor: 9.079
View more
  4 in total

1.  High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.

Authors:  Nicole Wolter; Anthony M Smith; Donald E Low; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

2.  Understanding the impact of antibiotic therapies on the respiratory tract resistome: a novel pooled-template metagenomic sequencing strategy.

Authors:  Steven L Taylor; Lex E X Leong; Fredrick M Mobegi; Jocelyn M Choo; Lucy D Burr; Steve Wesselingh; Geraint B Rogers
Journal:  Multidiscip Respir Med       Date:  2018-08-09

3.  Role of Bentonite on the Mobility of Antibiotic Resistance Genes, and Microbial Community in Oxytetracycline and Cadmium Contaminated Soil.

Authors:  Honghong Guo; Shuhong Xue; Mubasher Nasir; Jialong Lv; Jei Gu
Journal:  Front Microbiol       Date:  2018-11-28       Impact factor: 5.640

4.  Analysis of virulence factors and antibiotic resistance genes in group B streptococcus from clinical samples.

Authors:  Raymond Mudzana; Rooyen T Mavenyengwa; Muchaneta Gudza-Mugabe
Journal:  BMC Infect Dis       Date:  2021-01-28       Impact factor: 3.090
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.